Patients ≥ 18 years of age who had a diagnosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced/metastatic breast cancer (ABC/mBC) were enrolled in the prospective, observational, multicenter, real-world POLARIS study. The gene discussed is ERBB2; the disease is aneurysmal bone cyst.